Citigroup Downgraded Abbott Labs To Sell, Lowered Its PT To

Local News
3.2K
116 views
  • About
  • Add to
Citigroup downgraded Abbott Laboratories (NYSE:ABT) to sell from hold and lowered its price target to $44 from $48.The bank sees 2011 EPS of $4.52, vs. consensus estimates of $4.63 per share, and 2012 EPS of $4.68, vs. consensus estimates of $4.98 per share.Abbott Laboratories has a potential upside of 23.6% based on a current price of $46.47 and an average consensus analyst price target of $57.42.

0 comments